Interestingly, zoledronic acid has been shown to decrease expression of EMT-markers N-cadherin, Twist and Snail, while upregulating E-cadherin in triple-negative breast cancer cells [43]. The gene discussed is SNAI1; the disease is triple-negative breast carcinoma.